Fig. 3From: Identifying novel host-based diagnostic biomarker panels for COVID-19: a whole-blood/nasopharyngeal transcriptome meta-analysisCell-type proportions in whole blood of COVID-19 in comparison to healthy control: the box plots for the estimated immune cell type proportions of the COVID-19 patients and the HC individuals which were obtained by Cibersortx. HC healthy controlBack to article page